Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico

Neuromyelitis optica (NMO) is a severe demyelinating disease of the central nervous system, which preferentially attacks the optic nerve and spinal cord. It is associated with antibodies against aquaporin 4. Morbidity and mortality are higher than in multiple sclerosis and its treatment focuses on i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Suárez H,Felipe, Urrutia E,Daniela, Canales P,Felipe, Gutiérrez O,Camila
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2016
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872016000900020
record_format dspace
spelling oai:scielo:S0034-988720160009000202016-12-23Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínicoSuárez H,FelipeUrrutia E,DanielaCanales P,FelipeGutiérrez O,Camila Lupus Erythematosus, Systemic Neuromyelitis Optica Neuromyelitis optica (NMO) is a severe demyelinating disease of the central nervous system, which preferentially attacks the optic nerve and spinal cord. It is associated with antibodies against aquaporin 4. Morbidity and mortality are higher than in multiple sclerosis and its treatment focuses on immunosuppressive drugs. Immunomodulators are contraindicated. We report a previously healthy 35-year-old man, presenting with NMO concomitantly with systemic lupus erythematosus. His evolution was torpid with three outbreaks in the 10 months after the diagnosis, requiring a first-line therapy with methylprednisolone and cyclophosphamide and then a second-line therapy with rituximab.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.144 n.9 20162016-09-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900020es10.4067/S0034-98872016000900020
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Lupus Erythematosus, Systemic
Neuromyelitis Optica
spellingShingle Lupus Erythematosus, Systemic
Neuromyelitis Optica
Suárez H,Felipe
Urrutia E,Daniela
Canales P,Felipe
Gutiérrez O,Camila
Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
description Neuromyelitis optica (NMO) is a severe demyelinating disease of the central nervous system, which preferentially attacks the optic nerve and spinal cord. It is associated with antibodies against aquaporin 4. Morbidity and mortality are higher than in multiple sclerosis and its treatment focuses on immunosuppressive drugs. Immunomodulators are contraindicated. We report a previously healthy 35-year-old man, presenting with NMO concomitantly with systemic lupus erythematosus. His evolution was torpid with three outbreaks in the 10 months after the diagnosis, requiring a first-line therapy with methylprednisolone and cyclophosphamide and then a second-line therapy with rituximab.
author Suárez H,Felipe
Urrutia E,Daniela
Canales P,Felipe
Gutiérrez O,Camila
author_facet Suárez H,Felipe
Urrutia E,Daniela
Canales P,Felipe
Gutiérrez O,Camila
author_sort Suárez H,Felipe
title Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
title_short Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
title_full Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
title_fullStr Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
title_full_unstemmed Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico
title_sort neuromielitis óptica y lupus eritematoso sistémico en un hombre: caso clínico
publisher Sociedad Médica de Santiago
publishDate 2016
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016000900020
work_keys_str_mv AT suarezhfelipe neuromielitisopticaylupuseritematososistemicoenunhombrecasoclinico
AT urrutiaedaniela neuromielitisopticaylupuseritematososistemicoenunhombrecasoclinico
AT canalespfelipe neuromielitisopticaylupuseritematososistemicoenunhombrecasoclinico
AT gutierrezocamila neuromielitisopticaylupuseritematososistemicoenunhombrecasoclinico
_version_ 1718436906517135360